A C C E P T E D M A N U S C R I P T

Introduction
Preterm birth (PTB) is a substantial pregnancy complication, causing significant morbidity and mortality. A reduction in the rates of PTB has been hampered by difficulties in risk prediction, even A C C E P T E D M A N U S C R I P T within a high-risk population. Gender differences in adverse pregnancy outcomes have been described, including PTB, previously. In the low risk population, the male fetus has been shown to be at increased risk of preterm delivery. 1 This has been demonstrated in Western countries (OR 1.09 to 1.24) 1 , and appears to be more significant in white compared to black populations. 2 Males have also been found to be at greater risk of preterm prelabour rupture of membranes (PPROM), at all gestations. 3 Despite this male trend, the literature suggests an increase risk of pre-eclampsia in females, 3, 4 particularly evident in extremely preterm deliveries.
Our objective was to examine the risk effect for women at high-risk of PTB, and therefore its potential impact on targeting management. We hypothesized that within our high-risk cohort, the pregnancies associated with male fetuses would be at increased risk of PTB.
Materials and Methods
This was a secondary analysis of prospectively collected outcome data from a dedicated inner-city Prematurity Surveillance Clinic (PSC) between September 2001 and 2017. All women were high-risk for preterm delivery in view of their history, which included previous late miscarriage, PTB or significant cervical surgery. Women were referred to clinic from midwives, clinicians or were selfreferred. Women with multiple pregnancies were excluded from the analysis. Data was collected directly from patients or their medical notes and input into a secure online computerised database.
Women with unknown or indeterminate fetal gender, or unknown pregnancy outcome were excluded.
Our outcomes were PTB less than 37 weeks (spontaneous and iatrogenic), onset of labour (spontaneous or iatrogenic), confirmed pre-eclampsia, and preterm premature rupture of membranes (PPROM). PPROM was defined as rupture of membranes more than 1 hour prior to onset of weeks, preterm birth <32 weeks, preterm birth <37 weeks, PPROM and PET were presented as n (%).
Relative risk, Pearson's chi-square test, and 95% confidence intervals were calculated to compare these outcomes between the male and female gender groups. Similarly, secondary outcomes were presented as means +/-SD or n (%) and relative risk and chi square or t-tests were used to compare the outcomes. Analysis was performed using STATA (version 14.0); P<0.1 was taken as significant due to multiple hypothesis testing.
Results
Women were identified from an anonymous electronic database. 2516 asymptomatic high-risk women with singleton pregnancies and known fetal gender were identified who attended the Prematurity Surveillance Clinic. 11 were excluded due to unknown onset of labour. 2505 remained, of which 50.7% of women carried a male fetus (49.3% female). Overall, 14.5% (363) were delivered
before 37 weeks gestation. Of those born prematurely, 63.4% (230) were spontaneous and 36.6%
(133) were iatrogenic.
Patient characteristics (Table 1 ) and obstetric risk-factors (Table 2) were balanced between male and female sexes. Table 3 demonstrates the delivery outcomes of the women. At each gestational category, there was no significant difference for preterm delivery between the male and female fetus (all miscarriages <24
weeks;, preterm birth, 24 to 37 weeks, and also <28 weeks, <34 weeks and <37 weeks). This held true for both spontaneous and iatrogenic deliveries. When comparing the male risk of all PTB in the black cohort (RR 0.94, CI 0.70 to 1.24, p= 0.949) and white cohort (RR 1.30, CI 0.97 to 1.76, p=0.084) there appeared to be a stronger link between the male fetus and PTB in the white cohort, however these relative risks were not statistically significant.
There was no significant difference in delivery details, such as use of tocolysis, antibiotics and augmentation between fetal genders ( Table 4 ). The risk of PET was not significantly associated with fetal gender (RR= 0.93, 95% CI 0.61 to 1.41, p=0.725). Similarly, no differences were found in rates of PPROM (RR=1.14, 95% CI 0.86 to 1.50, p= 0.384). Finally, there was no significant difference in neonatal deaths between fetal gender, however numbers were small (n=6 female, n=8 male). As expected, there was a significant difference between the average birth weight of male and female fetuses, males were approximately 90g heavier (p=0.004).
Discussion
Our study demonstrates that there is no significant increased risk of miscarriage or PTB (spontaneous or iatrogenic) for the male fetus in women at high-risk of preterm birth based on their obstetric history. This is in contrast to current evidence in the low-risk population, which reports an increased relative risk of 1.11 5 to 1.5 6 and odds ratio of 1.4 7 for spontaneous preterm delivery in the male fetus.
The mechanism by which the male fetus predisposes to miscarriage and preterm birth in the low-risk population is unknown, with various proposed theories. It is been suggested that the placenta of the male fetus may react differently to adverse events. 8 A study reported increased infiltration of plasma cells in the basal plate, increased basal plate mononuclear lecucocytes and villitis, and increased uteroplacental chronic vasculitis within the male placenta. 9 Furthermore, lesions of chronic inflammation at the implantation site were more common in male compared to female placentas. 9 This may represent a more aggressive maternal inflammatory response to the male trophoblast, predisposing to risk of PTB. 9 Furthermore, mothers of male neonates born preterm have higher circulating pro-inflammatory cytokines, with lower anti-inflammatory IL 10 and GCSF. 4 Maternal cortisol was found to be higher from 24 to 30 weeks gestation in women carrying a male fetus, with a crossover at 30 weeks after which women carrying a female fetus has higher salivary cortisol. 10 Fetal gender may thereby affect the maternal hypothalamic-pituitary-adrenal axis and moderate fetal development and pregnancy outcome. It is thought there is a sex-specific interaction between mother, placenta and fetus which leads to differing pregnancy outcome and complications.
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In contrast, it has been hypothesized that increased male birth weight or antenatal complications may lead to increased iatrogenic preterm delivery, however studies have generally shown no increase in pre-labour caesarean or induction for the male fetus. 4 With our contradictory conclusions for high-risk pregnancies, we propose that the risk affect of male gender is only evident in the absence of significant competing risk factors or pathology, such as a history of preterm birth, PPROM or cervical surgery. These significant risk factors may overwhelm the small predisposing risks differences, for example immune tolerance, between genders.
Studies have demonstrated an increased risk of early-onset preeclampsia in women carrying a female fetus, with risk equalising towards term. 3, 12 No clear mechanism has been elucidated, current theories suggest oxidative stress, inflammatory activation, immunological factors and endothelial dysfunction play a role. 3 It is suggested that the testosterone peak in the first trimester in the male fetus suppresses the inflammatory activation and oxidative stress associated with pre-eclampsia, thereby exerting a protective effect for male fetuses 3 . This is in contrast to our study, which found no significant difference between genders, despite age, body mass index, and maternal history of hypertension being balanced between the groups, however there was a trend towards significance of increased female risk of PTB in the <28 week band.
Like PET, a variety of aetiological mechanisms have been suggested as the mechanism of action for
PPROM. Other studies have demonstrated an increased male/female ratio for PPROM throughout gestation. 3 PPROM involves the disruption of the membrane morphology and collagen network, and this is often related to bacterial infection or pro-inflammatory cytokines. Similarly, risk of disruption of the membrane is thought to be related to obstetric factors such as multiple pregnancy, polyhydramnios and cervical incompetence. Environmental, genetic, and behavioural factors such as smoking and substance use, which lead to increased oxidative stress have also been discussed.
Recently, telomere dependent aging of the fetal membranes and microfractures within the membranes have been implicated in the aetiology of PPROM. 13 However, our study found no increased risk of PPROM for the male fetus in high-risk mothers. Other factors may supersede the gender effect on risk of PPROM.
Other studies have demonstrated the risk effect of male gender in black populations to be less significant than white 2, 7 In our study our population was 31-33.5% black. However, in this study there was no statistically significant relative risk of PTB for males in either the white or black populationalthough we may be underpowered to demonstrate the effect of ethnicity. In addition, our population
had a mean age of 32, higher than the average in the UK (30), and many other countries. 14 Our conclusions can thus only be generalizable to similar race and age populations. Further work may be required to ascertain possible gender effects on subgroups. However currently, this is the largest highrisk cohort to date, with a PTB rate of 14.5%.
Conclusion
In a high-risk multi-cultural cohort presenting to a prematurity clinic in London, there was no significant increased risk of miscarriage, spontaneous or iatrogenic PTB, preeclampsia or PPROM for the male gender fetus. This is contradictory to the current literature in low-risk populations and suggests that gender may not be useful in risk management protocols for women at high-risk of preterm birth.
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